Scientists from the Broad Institute of Massachusetts Institute of Technology and Harvard have developed a first-of-its-kind cross-tissue cell atlas, and in collaboration with a team of Mass Eye and...
Ocugen, Inc. has obtained an exclusive worldwide license to develop and commercialize future ophthalmology products based on groundbreaking technology developed by Neena Haider, PhD, Associate...
Findings may lead to earlier diagnoses and better prognostic information for patients — and, potentially, new pharmaceutical targets for AMD treatment.
Boston, Mass. —Massachusetts Eye and Ear opened a new ophthalmology (eye care) practice at 578 Main Street in Malden, Mass., on March 6. Mass. Eye and Ear, Malden is the hospital’s 19th location...
Boston, Mass. — Researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have uncovered two factors responsible for the chronic, lifelong nature of autoimmune disorders, which...
Boston, Mass. — Luk H. Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear and an Assistant Professor of Ophthalmology at Harvard Medical School, has been...
Boston, Mass. — Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by...
Findings published in the American Journal of Pathology offer new directions for treatment of patients with Fuchs’ Endothelial Corneal Dystrophy (FECD)
The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented...
Ann Arbor, Mich. — Eversight, a global non-profit network of eye banks, has awarded an Eye and Vision Research grant to Ula V. Jurkunas, MD (pictured), and Shivakumar Vasanth, PhD. Dr. Jurkunas is a...
Boston, Mass. — The Department of Ophthalmology at Harvard Medical School has been granted a $30,000 Research to Prevent Blindness (RPB) Medical Student Research Fellowship in support of Priya Gupta...
Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug...
Mass. Eye and Ear researchers have designed technology to improve upon the built-in zoom feature of smartphones, which many low-vision users find difficult to use due to a loss of context.
A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and...
Researchers at Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that contribute to optic nerve damage following keratoprosthesis (KPro) implantation in a mouse...
Mass. Eye and Ear/Harvard Medical School neuro-ophthalmologist and researcher awarded funding by the Department of Defense Congressionally Directed Medical Research Programs.
Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in...
Mass. Eye and Ear and the Harvard Medical School Department of Ophthalmology are proud to be leading this important clinical trial. We look forward to reporting on safety and efficacy studies in the...
